The widespread hunt for candidates who are equally versed in tech and healthcare is making AI recruiting a challenge.

Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural hearing loss, with milestone payments exceeding $1.3 billion. Rznomics will ...

INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE ... This scholarship program supports high-achieving students from underresourced backgrounds who are pursuing an education ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

Donald Kimmel, 78, retired from his career as a biologist 16 years ago but continues to peer review articles and mentor young ...

Sollus Health, a leader in non-invasive Transcranial Magnetic Stimulation "TMS" treatment in California, today announced the appointment of Amy Stickler, Director of Global Strategic Initiatives at ...

FOR Hope Lancaster Colquhoun, her perfect smile had always been a source of pride – so it was a moment of pure horror when ...

Summer bridge programs have long helped students from underrepresented backgrounds start their college journey. In the ...

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the ...

In addition, Augustine today announced the founding of a Copenhagen, Denmark based subsidiary, Augustine Therapeutics Denmark ApS, which will serve as the company's hub for research related to ...